Pharmaceutical Glass Packaging Market Size, Share, Growth Analysis, By Material (Type I, Type II), By Product (Vials, Bottles), By Drug Type (Generic, Branded), By Region - Industry Forecast 2025-2032

Global Pharmaceutical Glass Packaging Market size was valued at USD 18 billion in 2022 and is poised to grow from USD 19.9 billion in 2023 to USD 41.7 billion by 2031, growing at a CAGR of 9.7% during the forecast period (2024-2031). 

The global pharmaceutical glass packaging market has access to its top players who compete aggressively by continually coming up with new ideas, output, and environmentally friendly practices to retain their competitive edge. The market is characterized by the presence of large corporations such as Corning Inc, Schott AG, SGD Pharma, Owens-Illinois, and Geeresheimer AG which manufacture and supply a wide range of glass packaging products including vials, bottles, and ampoules. These companies are investing in advanced manufacturing technologies and meeting stringent regulatory standards to address the rising demand for pharmaceutical packaging, especially for biologics and injectables. 'Gerresheimer AG (Germany) ', 'Corning Incorporated (USA) ', 'Nipro Corporation (Japan) ', 'SGD SA (SGD Pharma) (France) ', 'Stölzle-Oberglas GmbH (CAG Holding GmbH) (Austria) ', 'Bormioli Pharma S.p.A. (Italy) ', 'West Pharmaceutical Services Inc. (USA) ', 'Schott AG (Germany) ', 'Shandong Pharmaceutical Glass Co. Ltd. (China) ', 'Beatson Clark (United Kingdom) ', 'Arab Pharmaceutical Glass Co. (Egypt) ', 'Piramal Glass Private Limited (Piramal Group) (India) ', 'Sisecam Group (Turkey) ', 'Verallia (France) ', 'Shandong Yaowei Pharmaceutical Glass Co., Ltd. (China) ', 'Zhejiang Huachuang Pharmaceutical Glass Co., Ltd. (China) ', 'Changzhou Huaxing Pharmaceutical Glass Co., Ltd. (China) ', 'Jiangsu Huaxing Pharmaceutical Glass Co., Ltd. (China) ', 'Jiangsu Kaidi Pharmaceutical Glass Co., Ltd. (China) ', 'Jiangsu Yikang Pharmaceutical Glass Co., Ltd. (China)'

The rise in the use of biologics like monoclonal antibodies and vaccine will be a leading growth factor for the expansion of the global pharmaceutical glass packaging market. Biologics entail safe, sterile, and high-grade packaging to ensure their effectiveness, and this boosts the growth in demand for glass vials and syringes within the health sector.

Growing Demand for Biologic Drug Packaging: The increasing usage of biologics including, but not limited to, vaccines and monoclonal antibodies is driving the need for specialized glass packaging. Glass vials as well as syringes create a safe and sterile environment essential for the maintenance of stability and efficacy of these sensitive drugs which in turn causes packaging solutions to advance.

Asia-Pacific dominates the global pharmaceutical glass packaging market due to its rapidly expanding healthcare sector, large population base, and growing pharmaceutical production. The enhanced requirement for generic and biologic medicines in the region, coupled with the increased healthcare awareness calls for high-grade packaging solutions. In addition, the region is favored due to cheap production costs and supportive government policies for the pharmaceutical sector. As India and China are becoming major centers for the manufacture of pharmaceuticals, the need for the packaging of such medical products in glass vials, bottles, and ampoules is expected to increase, thereby reinforcing the Asia-Pacific regions dominance in the global pharmaceutical glass packaging market outlook.